BioCentury
ARTICLE | Company News

Management tracks: Brickell, Genevant

November 19, 2018 11:44 PM UTC

Dermatology company Brickell Biotech Inc. (Boulder, Colo.) hired Robert Brown as CEO, effective Jan. 1. He will replace co-founder and CEO Reginald Hardy, who will remain on the board and serve as special adviser to the CEO. Brown is chief marketing officer and SVP at Eli Lilly and Co. (NYSE:LLY).

Genevant Sciences said CSO, President and Head of R&D Bo Rode Hansen will transition to CEO and president. A Genevant spokesperson told BioCentury the company is determining how best to fill his prior positions. Before joining the company in April, Hansen was global head of RNA therapeutics at Roche (SIX:ROG; OTCQX:RHHBY) and general manager of the Roche Innovation Center Copenhagen. ...